Denmark has decided to permanently stop the use of the AstraZeneca vaccine. It is the first country in Europe to deliver such a verdict. The Scandinavian country was also the first to suspend the administration of the serum last March, followed then by many countries, including France.
Denmark abandons AstraZeneca
It was Søren Brostrøm, director of the National Health Agency, who made the announcement at a press conference: “ the vaccination campaign in Denmark continues without the AstraZeneca vaccine. This renunciation of this serum is linked to rare side effects, but serious (atypical thrombosis). However, the European Medicines Agency has come out in favor of the AstraZeneca vaccine because the benefits outweigh the risks. However, the link has been confirmed between blood clots and AstraZeneca vaccine, which have also been added to the list of rare adverse events. The recommendations have since evolved: this vaccine is recommended for people aged 55 and over.
Another vaccine in second dose
Therefore, people who have already received a first injection with the Anglo-Swedish vaccine will receive another vaccine as a second dose. This concerns around 150,000 Danes.
In France, the second dose inoculated is an RNA vaccine, such as the serum from Pfizer or Moderna, for people under the age of 55. The vaccination of these patients will be monitored ” in real time “. Five hundred thousand citizens are concerned.
